Monday, August 29, 2016

Zika Virus Vaccine Overturns Pharma Industry Playbook (GSK, SNY, ION) : investopedia





As it stated in investopedia

Zika Virus Vaccine Overturns Pharma Industry Playbook (GSK, SNY, ION)

Zika Virus Vaccine Overturns Pharma Industry Playbook (GSK, SNY, ION)
Zika Virus Vaccine Overturns Pharma Industry Playbook (GSK, SNY, ION)
In addition to making headlines at the Rio Olympics, the Zika virus has also overturned the pharmaceutical industry's playbook.With cases of active transmission reported in 54 countries (and 2,517 of such cases in the United States alone), the virus should have drawn the attention of big pharmaceutical companies which could earn revenues and serious brand credibility if they developed a vaccine for it.After all, the market for vaccines is expected to reach $61 billion in profits by 2020 and big pharma has the funds and expertise necessary.


by the same token on wbtw

Florence County Environmental Services fight the Zika Virus

Florence County Environmental Services fight the Zika Virus
Florence County Environmental Services fight the Zika Virus
FLORENCE, S.C. (WBTW) – News13 had an inside look at the steps Florence County is taking to prevent the spread of the Zika virus.The County has set up traps to catch mosquitoes to test them for the virus.A South Florence woman was diagnosed with Zika last month after traveling to an area with Zika.


by the same token on nbcdfw

Denton Resident Tests Positive for Zika Virus

Denton Resident Tests Positive for Zika Virus
Denton Resident Tests Positive for Zika Virus
City leaders are preparing to spray for mosquitoes in a southwest Denton neighborhood after a resident contracted the Zika virus while traveling abroad.(Published Monday, Aug. 29, 2016)City leaders are preparing to spray for mosquitoes in a southwest Denton neighborhood after a resident contracted the Zika virus while traveling abroad.The Denton County Health Department alerted the city about the case late Friday.


Zika Virus Vaccine Overturns Pharma Industry Playbook (GSK, SNY, ION)

No comments:

Post a Comment